Bernstein analyst James Hooper reaffirmed a Buy rating on BASF on Tuesday, holding his price target at 61 euros. The endorsement lands just ahead of the group’s third-quarter 2026 results, due on 28 October 2026, which will serve as the next hard test for the stock. Until then, investors face a patchwork of announcements that differ sharply in how binding they actually are.
That distinction is the thread running through BASF’s recent news flow. Some items are done deals, others are signed but non-binding, and at least one is little more than a willingness to keep talking.
Completed: the share buyback
The most concrete item is already in the books. BASF reported on Monday that it repurchased 451,622 of its own shares between 12 and 16 October inclusive, executed under its ongoing buyback programme. These are settled transactions rather than expressions of intent, which sets them apart from the strategic announcements that followed.
The buyback, however, says nothing about operating performance. Whether Bernstein’s positive view will be borne out by actual business trends cannot be inferred from the share purchases — that answer rests with the upcoming earnings release.
Non-binding: Taiwan and the nylon venture
On Tuesday, BASF signed a memorandum of understanding with Taiwan’s Ministry of Economic Affairs to expand its Taoyuan site. The plan envisages additional capacity for semiconductor materials, upgraded quality analysis and a larger innovation centre, all aimed at supporting chip technologies below 2 nanometres. According to the company, no specific investments or binding projects were named — the agreement maps out a direction of travel, not capacity that already exists.
Should investors sell immediately? Or is it worth buying BASF?
A day earlier, BASF disclosed a separate arrangement with Highsun Holding Group. The two firms will examine combining their European polyamide-6 value-chain activities into a possible 50:50 joint venture, and they are also reviewing whether to fold in their worldwide extrusion operations outside North America. The letter of intent is explicitly non-binding, so both the scope and the execution of any combination remain open.
Evonik: talking, not bidding
The possible Evonik acquisition follows the same logic of separating dialogue from commitment. A dpa-AFX report last week said BASF would be prepared to discuss a higher offer, but only after gaining access to Evonik’s books. A person familiar with the transaction cited that condition to the news agency. Evonik had rejected the initial bid of 22.15 euros per share as too low, and no binding new offer was on the table, according to the report. Willingness to keep negotiating should not be read as a raised bid.
Awards for circular-plastics pilots
Friday brought recognition of a different kind: BASF won the MATERIALICA Award 2026 and second place at the Fakuma Innovation Award 2026 for two pilot projects on recycling technical plastics. The honours relate to specific pilot work and stand apart from the open structural and takeover questions.
Ahead of the quarterly figures, the picture splits cleanly. The buyback has been executed, Bernstein has restated its Buy case, and the joint ventures, site expansion and Evonik soundings remain proposals. Those status gaps matter more than any single narrative treating every announcement as realised progress — strategic options and financial results are measured on different scales.
Ad
BASF Stock: Buy or Sell?! New BASF Analysis from October 22 delivers the answer:
The latest BASF figures speak for themselves: Urgent action needed for BASF investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 22.
BASF: Buy or sell? Read more here...
